Coal tar 20% / Zinc oxide 15% in Yellow soft paraffin
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 13 · Randomised trials: 1 · 1981–2026
Showing the 50 most relevant studies, sorted by most relevant.
Akash Roshan, Dipita Ghosh, Subodh Kumar Maiti
Carbon Research, 2023
Mrinal Gupta, Vikram K. Mahajan, Karaninder S. Mehta, et al.
Dermatology Research and Practice, 2014
Ning Han, Wei Zhang, Wei Guo, et al.
Nano-Micro Letters, 2023
Nan Zhu, Haining Ji, Peng Yu, et al.
Nanomaterials, 2018
Christoph F. A. Vogel, Laura S. Van Winkle, Charlotte Esser, et al.
Redox Biology, 2020
- Polycyclic Aromatic Hydrocarbons
- Receptors, Aryl Hydrocarbon
- Gene Expression Regulation
Fang Dong, Mingjie Wu, Zhangsen Chen, et al.
Nano-Micro Letters, 2021
Al-Gamal AG, Gado WS, Abo El-Khair MA, et al.
2024
Asphalt is widely used as a coating resin due to its excellent adhesion strength and cost-effectiveness; however, its limited corrosion protection necessitates enhancement. In this study, poly(amidoamine) (PAMAM), combined with zinc oxide (ZnO) nanoparticles, was incorporated into the asphalt matrix to improve its anticorrosive properties. Various ratios of PAMAM-ZnO nanocomposite (1, 2, 4, and 6% by weight) were added to the asphalt binder, with the materials characterized using XRD, ¹H-NMR, and SEM techniques. The 2% PAMAM-ZnO/asphalt ratio exhibited the most significant improvement, achieving a corrosion protection efficiency (η%) of 97.93%, as confirmed by Tafel analysis, and a charge transport resistance (RCT) of 75.91 Ω cm² according to electrochemical impedance spectroscopy (EIS) data. A combination of barrier formation and sacrificial protection drives the corrosion inhibition mechanism. The PAMAM-ZnO nanocomposite forms a highly uniform layer on the carbon steel surface, creating an effective physical barrier that prevents the penetration of corrosive agents, thereby minimizing defects like pinholes. This barrier effect is complemented by the sacrificial protection provided by the ZnO nanoparticles, which are more reactive than the underlying steel and preferentially interact with corrosive ions (e.g., chloride ions). This interaction leads to the formation of stable ZnO corrosion products, which enhance the barrier and reduce the likelihood of corrosion on the steel surface. Additionally, PAMAM facilitates the even distribution and strong adhesion of ZnO within the asphalt matrix, ensuring a durable protective layer. The synergic impact between the polymer barrier and sacrificial ZnO protection results in the exceptional corrosion resistance observed in the 2% PAMAM-ZnO/asphalt formulation, offering a promising approach for advanced anticorrosive coatings.
Abstract licence: CC BY
Qian Liu, Dongling Wu, Tao Wang, et al.
Advanced Functional Materials, 2024
Syed Zakir Hussain, Muhammad Ihrar, Syed Babar Hussain, et al.
SN Applied Sciences, 2020
Sohan Bir Singh, Noah T. Haskin, Seyed A. Dastgheib
Carbon, 2023
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.